OB-Tools Overview
OB-Tools develops technology designed to monitor uterine contractions. The company has developed the TrueLabor System with LaborTrack Technology, a noninvasive device that is designed to help maternal fetal medicine specialists and obstetricians identify, measure, and evaluate uterine contractions and fetal heart rates throughout pregnancy and labor. The TrueLabor System helps doctors and nurses distinguish between true and false labor signs. The companys maternal fetal monitor is highly accurate, providing safe and secure readings even in the most difficult conditions. OB-Tools fetal heart rate monitoring unit received FDA approval in 2015.
Latest News
growth-positive
OB-Tools to Start Marketing its Non-Invasive Labor Monitoring Device Following FDA Approval
OB-Tools has received FDA approval for its fetal heart rate monitoring unit, which will be integrated into its TrueLabor[TM] maternal fetal monitor. The monitor is non-invasive and uses electrodes attached to the abdomen to measure uterine contractions and fetal heart beats. The devices algorithm filters out excess noise and can distinguish between true and false contractions. Clinical trials have found the technology to be more reliable than external fetal monitors and as accurate as invasive monitors. The TrueLabor[TM] system is expected to begin sales in the US in Q4 2015 and in Europe in Q1 2016.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Mature |
| Rounds | 0 |
| Investors | 0 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | ob-tools.com |
Locations
HaHaroshet 4, Nesher, Israel
Photos & Videos
1 item(s)
